Literature DB >> 20553054

A decade of data mining and still counting.

Manfred Hauben, G Niklas Norén.   

Abstract

Mesh:

Year:  2010        PMID: 20553054     DOI: 10.2165/11532430-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  21 in total

1.  A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database.

Authors:  M Lindquist; M Ståhl; A Bate; I R Edwards; R H Meyboom
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

2.  Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.

Authors:  Corneliu Henegar; Cédric Bousquet; Agnès Lillo-Le Louët; Patrice Degoulet; Marie-Christine Jaulent
Journal:  Comput Biol Med       Date:  2005-09-26       Impact factor: 4.589

Review 3.  Perspectives on the use of data mining in pharmaco-vigilance.

Authors:  June Almenoff; Joseph M Tonning; A Lawrence Gould; Ana Szarfman; Manfred Hauben; Rita Ouellet-Hellstrom; Robert Ball; Ken Hornbuckle; Louisa Walsh; Chuen Yee; Susan T Sacks; Nancy Yuen; Vaishali Patadia; Michael Blum; Mike Johnston; Charles Gerrits; Harry Seifert; Karol Lacroix
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Data mining in spontaneous reports.

Authors:  Andrew Bate; I R Edwards
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

5.  Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.

Authors:  June S Almenoff; Karol K LaCroix; Nancy A Yuen; David Fram; William DuMouchel
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Illusions of objectivity and a recommendation for reporting data mining results.

Authors:  Manfred Hauben; Lester Reich; Charles M Gerrits; Muhammad Younus
Journal:  Eur J Clin Pharmacol       Date:  2007-03-16       Impact factor: 2.953

Review 7.  Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

9.  Epidemiology faces its limits.

Authors:  G Taubes
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

10.  Time-to-signal comparison for drug safety data-mining algorithms vs. traditional signaling criteria.

Authors:  A M Hochberg; M Hauben
Journal:  Clin Pharmacol Ther       Date:  2009-03-25       Impact factor: 6.875

View more
  17 in total

1.  An experimental investigation of masking in the US FDA adverse event reporting system database.

Authors:  Hsin-wei Wang; Alan M Hochberg; Ronald K Pearson; Manfred Hauben
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

2.  A Multiagent System for Integrated Detection of Pharmacovigilance Signals.

Authors:  Vassilis Koutkias; Marie-Christine Jaulent
Journal:  J Med Syst       Date:  2015-11-21       Impact factor: 4.460

3.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

4.  Using information mining of the medical literature to improve drug safety.

Authors:  Kanaka D Shetty; Siddhartha R Dalal
Journal:  J Am Med Inform Assoc       Date:  2011-05-05       Impact factor: 4.497

5.  Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.

Authors:  Johanna Strandell; Ola Caster; Andrew Bate; Niklas Norén; I Ralph Edwards
Journal:  Drug Saf       Date:  2011-03-01       Impact factor: 5.606

6.  Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance.

Authors:  G Niklas Norén; Ola Caster; Kristina Juhlin; Marie Lindquist
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

7.  Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance.

Authors:  Manfred Hauben; Eric Y Hung
Journal:  Ther Adv Drug Saf       Date:  2016-05-23

8.  The hope, hype and reality of Big Data for pharmacovigilance.

Authors:  Andrew Bate; Robert F Reynolds; Patrick Caubel
Journal:  Ther Adv Drug Saf       Date:  2017-10-31

9.  The impact of database restriction on pharmacovigilance signal detection of selected cancer therapies.

Authors:  Manfred Hauben; Eric Hung; Jennifer Wood; Amit Soitkar; Daniel Reshef
Journal:  Ther Adv Drug Saf       Date:  2017-02-01

10.  Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection.

Authors:  Rong Xu; QuanQiu Wang
Journal:  BMC Bioinformatics       Date:  2014-01-15       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.